22 July 2026
22 July 2026
It began with a story.
The auditorium was dark, except for a spot of light illuminating a corner of the stage where we could see a young woman in a red dress with a book in her hands, sitting in a red armchair beside a little table holding a mug and some books, a reading-lamp, and a stack of books lying on an orange carpet.
The storyteller was Saheli Roy, a PhD student in Neuroscience at the Champalimaud Foundation and one of the co-hosts for the evening. She read the beginning of an Indian story about kingdoms and pretenders to the throne.
16 July 2026
To us, Tonegawa was not only a giant of world science, he was also a cherished friend of the Champalimaud Foundation.
Present from the Champalimaud Foundation's earliest and most formative years, he helped shape its scientific DNA, contributing to the model that continues to guide us today: science that is ambitious, rigorous and committed to making a real difference to people's lives.
8 September 2026, 14:00 – 18:15
Seminar Room, Champalimaud Foundation, Lisbon
Over the past two decades, psychedelic research has generated evidence of the therapeutic potential across a range of psychiatric and neurological conditions, bringing new possibilities for treatment and care. As the field continues to advance rapidly, clinical research still needs to overcome current challenges in real-world implementation of psychedelic therapy.
06 July 2026
Obsessive-compulsive disorder (OCD) can be an extremely incapacitating neuropsychiatric condition. The symptoms of people who suffer from OCD can entail washing their hands or showering over and over again, repeatedly checking whether they switched off the gas in the kitchen or locked their street door. In the most extreme cases, this takes up so much of their time and energy that they become unable to leave their house, to work, to develop meaningful relationships and to interact with other people.